Sponsor
Airna Corp.
1 Kendall Square Building 300, 02139-1562, United States
About the sponsor
Airna Corp. focuses on clinical research in Alpha-1 Antitrypsin Deficiency, a genetic disorder associated with impaired alpha-1 antitrypsin function and related organ complications. The sponsor’s trial activity is centered on therapeutic development for this rare disease area, with interest in conditions affecting lung and liver health.
- Genetic rare disease
- Alpha-1 antitrypsin biology
- Pulmonary disease
- Hepatic disease
The research portfolio reflects a therapeutic emphasis on addressing the underlying biology of AATD and its systemic consequences.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.